pediatric acute lymphoblastic leukemia

Changes in Height and Body Mass Index in Children Undergoing Chemotherapy for Acute Lymphoblastic Leukemia
Genome-wide polymorphisms linked to treatment dosing and outcomes in Qatari pediatric acute lymphoblastic leukemia
Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in Resource-Limited Setting
Navigating Glycemic Gush in Pediatric ALL: The Pill perspective
Peg-Asparaginase Associated Toxicities in Children with Acute Lymphoblastic Leukemia
Evaluating the risk factors and outcomes of neutropenic colitis in children with acute lymphoblastic leukemia during chemotherapy